Loading organizations...
Key people at National Institute on Drug Abuse.
The National Institute on Drug Abuse (NIDA) spearheads federal scientific research on drug use and addiction. It investigates biological, behavioral, and social aspects of substance abuse, translating this into evidence-based prevention and treatment strategies. NIDA's approach includes basic, clinical, and epidemiological studies across substances, tackling complex public health challenges.
NIDA was established by an act of the U.S. Congress on May 14, 1974. This legislative creation addressed a national imperative for centralized scientific inquiry into drug abuse, distinct from individual founders. As a core component of the National Institutes of Health, NIDA provides a robust scientific foundation for combating substance use disorders.
NIDA’s research informs public health officials, healthcare providers, and policymakers. Its vision focuses on improving public health by translating scientific discoveries into effective interventions and educational resources. The institute fosters innovative research, aiming to reduce drug addiction’s societal impact through practical prevention and recovery solutions.
Key people at National Institute on Drug Abuse.
National Institute on Drug Abuse has 3 tracked investments across 3 companies. The latest tracked deal is $14.0M Grant in Gilgamesh Pharmaceuticals in March 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 14, 2024 | Gilgamesh Pharmaceuticals | $14.0M Grant | National Institute ON Drug Abuse | — |
| Oct 25, 2023 | CARI Health | $2.8M Grant | National Institute ON Drug Abuse | — |
| Aug 17, 2010 | Selecta Biosciences | $3.0M Grant | National Institute ON Drug Abuse | — |